Intravenous immunoglobulin effective against dermatomyositis: NEJM Medha Baranwal6 Oct 2022 2:00 PM GMTDelhi: Intravenous immune globulin (IVIG) treatment in patients with dermatomyositis confers more significant improvement in disease activity compared...
JAK inhibitors promising for treatment of psoriasis and psoriatic arthritis Jacinthlyn Sylvia5 Oct 2022 2:30 PM GMTCanada: The treatment of moderate-to-severe psoriasis and psoriatic arthritis (PsA) with Janus Kinase (JAK) inhibitors is safe and appears promising,...
Early initiation of emollient use prevents atopic dermatitis incidence in high-risk infants: Study Jacinthlyn Sylvia4 Oct 2022 2:30 PM GMTA recent study by Chaoimh and team has found that early initiation of regular emollient use for 2 months lowers the incidence of Atopic Dermatitis...
Tildrakizumab therapy proves beneficial for Plaque Psoriasis Dr. Kamal Kant Kohli3 Oct 2022 2:30 PM GMTITALY: Tildrakizumab was found to be beneficial for up to 36 weeks in treating moderate-to-severe plaque psoriasis, according to a new study published...
FDA approves dupilumab as first and only treatment Indicated for Prurigo Nodularis Dr. Kamal Kant Kohli2 Oct 2022 2:00 PM GMTPrurigo nodularis is a chronic, debilitating skin disease with underlying type 2 inflammation and its impact on quality of life is one of the highest...
Chronic Low Sleep Deprivation may increase risk of SLE, finds study Dr.Niharika Harsha B30 Sep 2022 2:00 PM GMTThe latest research revealed that Chronic low sleep duration was associated with an increased risk of developing Systemic Lupus Erythematosus. The...
Mycophenolate mofetil and methotrexate efficacy in dermatomyositis-BJD study Dr Manoj Kumar Nayak29 Sep 2022 3:15 AM GMTMycophenolate mofetil and methotrexate efficacy in dermatomyositis- BJD study Dermatomyositis is a rare connective tissue disease characterized by...
Immunotherapy before targeted therapy significantly improves advanced melanoma survival Isra Zaman28 Sep 2022 4:15 AM GMTA clinical trial led by clinicians at Georgetown Lombardi Comprehensive Cancer Center showed a remarkable 20 percent advantage in the two-year overall...
Roflumilast cream effective for treating plaque psoriasis: JAMA Dr. Kamal Kant Kohli26 Sep 2022 2:00 PM GMTUSA: According to a study published in JAMA Network, roflumilast cream was effective in treating plaque psoriasis in patients after 8 weeks of...
Rodents are pools for life-threatening disease: Study Isra Zaman26 Sep 2022 9:55 AM GMTFungal diseases in the human population are on the rise, so it is important for health authorities to understand where these pathogens come from. A...
Fatigue independently associated with disease activity in SLE Dr.Niharika Harsha B25 Sep 2022 2:00 PM GMTA recent study found that Fatigue and disease activity are independent factors as found using the Physician Global Assessment (PGA). The study was...
JAMA study reports drug-induced lupus erythematosus in users of proton pump inhibitors Medha Baranwal23 Sep 2022 3:00 PM GMTFrance: In case of suspected cases of drug-induced lupus erythematosus (DILE), proton pump inhibitors (PPIs) should be considered as a potential...
